$2.67 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 41.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $515,070,000 | -28.5% | 4,500,000 | +3.4% | 19.29% | -13.1% |
| IWM | New | ISHARES TRcall | $320,488,000 | – | 2,800,000 | +100.0% | 12.00% | – |
| HYG | New | ISHARES TRput | $192,675,000 | – | 2,500,000 | +100.0% | 7.22% | – |
| CVNA | Buy | CARVANA COcall | $100,589,000 | -29.5% | 1,825,900 | +17.7% | 3.77% | -14.3% |
| QURE | Buy | UNIQURE NV | $81,105,000 | -15.0% | 1,709,272 | +28.3% | 3.04% | +3.3% |
| W | Buy | WAYFAIR INCcl a | $69,893,000 | +113.1% | 1,307,870 | +260.4% | 2.62% | +159.2% |
| CDXS | CODEXIS INC | $59,856,000 | -30.2% | 5,363,484 | 0.0% | 2.24% | -15.1% | |
| W | Buy | WAYFAIR INCcall | $59,495,000 | +119.4% | 1,113,300 | +271.1% | 2.23% | +166.8% |
| VAC | Buy | MARRIOTT VACTINS WORLDWID CO | $53,639,000 | -36.7% | 965,079 | +46.6% | 2.01% | -23.1% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $49,721,000 | +16.8% | 6,559,478 | -2.6% | 1.86% | +41.9% |
| RH | Buy | RH | $48,043,000 | +1164.6% | 478,180 | +2587.5% | 1.80% | +1437.6% |
| QADA | Sell | QAD INCcl a | $46,873,000 | -26.4% | 1,173,868 | -6.1% | 1.76% | -10.5% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcall | $45,382,000 | -71.7% | 4,678,600 | -21.9% | 1.70% | -65.6% |
| DLB | Buy | DOLBY LABORATORIES INC | $45,357,000 | +26.4% | 836,693 | +60.4% | 1.70% | +53.6% |
| QURE | Sell | UNIQURE NVcall | $43,298,000 | -47.7% | 912,500 | -21.0% | 1.62% | -36.4% |
| HCA | Buy | HCA HEALTHCARE INCput | $42,230,000 | -10.7% | 470,000 | +46.9% | 1.58% | +8.6% |
| CASH | META FINL GROUP INC | $39,090,000 | -40.5% | 1,799,727 | 0.0% | 1.46% | -27.7% | |
| Buy | APTOSE BIOSCIENCES INC | $37,417,000 | +9.0% | 6,299,196 | +4.1% | 1.40% | +32.5% | |
| CUE | Buy | CUE BIOPHARMA INC | $35,529,000 | +59.3% | 2,503,840 | +78.2% | 1.33% | +93.7% |
| THC | Sell | TENET HEALTHCARE CORPcall | $34,596,000 | -65.0% | 2,402,500 | -7.6% | 1.30% | -57.4% |
| LXFR | LUXFER HOLDINGS PLC | $34,396,000 | -23.6% | 2,432,531 | 0.0% | 1.29% | -7.1% | |
| KRE | New | SPDR SER TRput | $32,590,000 | – | 1,000,000 | +100.0% | 1.22% | – |
| VG | New | VONAGE HLDGS CORP | $31,239,000 | – | 4,320,800 | +100.0% | 1.17% | – |
| THC | Buy | TENET HEALTHCARE CORP | $30,689,000 | -26.8% | 2,131,171 | +93.4% | 1.15% | -11.0% |
| HCA | New | HCA HEALTHCARE INC | $28,701,000 | – | 319,434 | +100.0% | 1.08% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $27,824,000 | +15.4% | 1,925,569 | +120.8% | 1.04% | +40.2% |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $26,535,000 | -12.3% | 2,906,378 | +15.7% | 0.99% | +6.7% |
| WRLD | Buy | WORLD ACCEP CORP DEL | $20,047,000 | -26.7% | 367,088 | +15.9% | 0.75% | -10.9% |
| DXPE | DXP ENTERPRISES INC NEW | $19,646,000 | -69.2% | 1,602,433 | 0.0% | 0.74% | -62.5% | |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $18,964,000 | -38.1% | 5,003,631 | +3.2% | 0.71% | -24.8% |
| MED | Buy | MEDIFAST INC | $17,060,000 | +19.8% | 272,957 | +110.0% | 0.64% | +45.6% |
| FRG | FRANCHISE GROUP INC | $16,657,000 | -61.9% | 1,910,247 | 0.0% | 0.62% | -53.6% | |
| TBBK | BANCORP INC DEL | $16,292,000 | -53.2% | 2,683,938 | 0.0% | 0.61% | -43.1% | |
| GDEN | GOLDEN ENTMT INC | $16,193,000 | -65.6% | 2,449,713 | 0.0% | 0.61% | -58.2% | |
| UAL | New | UNITED AIRLS HLDGS INCcall | $15,775,000 | – | 500,000 | +100.0% | 0.59% | – |
| WYND | New | WYNDHAM DESTINATIONS INC | $14,986,000 | – | 690,620 | +100.0% | 0.56% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $14,496,000 | – | 1,005,302 | +100.0% | 0.54% | – |
| SGMS | Buy | SCIENTIFIC GAMES CORP | $14,380,000 | -62.4% | 1,482,465 | +3.9% | 0.54% | -54.2% |
| UPLD | New | UPLAND SOFTWARE INC | $13,875,000 | – | 517,346 | +100.0% | 0.52% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $13,106,000 | -39.9% | 2,852,260 | 0.0% | 0.49% | -26.8% | |
| CVNA | Buy | CARVANA COcl a | $11,726,000 | +21220.0% | 212,851 | +35673.3% | 0.44% | +21850.0% |
| ALTG | New | ALTA EQUIPMENT GROUP INC | $10,294,000 | – | 2,410,887 | +100.0% | 0.39% | – |
| DHX | DHI GROUP INC | $10,187,000 | -30.1% | 4,839,595 | 0.0% | 0.38% | -14.9% | |
| SLNO | SOLENO THERAPEUTICS INC | $10,181,000 | -19.1% | 4,277,923 | 0.0% | 0.38% | -1.6% | |
| FTACU | Buy | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $9,995,000 | +9.8% | 977,022 | +15.9% | 0.37% | +33.1% |
| SCPL | Buy | SCIPLAY CORPcl a | $9,535,000 | -17.1% | 1,001,032 | +7.0% | 0.36% | +0.8% |
| JYNT | JOINT CORP | $9,210,000 | -32.8% | 848,881 | 0.0% | 0.34% | -18.2% | |
| WVE | New | WAVE LIFE SCIENCES LTD | $9,131,000 | – | 974,472 | +100.0% | 0.34% | – |
| CAR | New | AVIS BUDGET GROUPcall | $9,142,000 | – | 657,700 | +100.0% | 0.34% | – |
| CRHM | Buy | CRH MED CORP | $9,063,000 | -60.0% | 6,777,905 | +3.7% | 0.34% | -51.4% |
| EXAS | Sell | EXACT SCIENCES CORPput | $8,700,000 | -76.9% | 150,000 | -63.2% | 0.33% | -71.9% |
| SIGA | Buy | SIGA TECHNOLOGIES INC | $8,643,000 | +2.9% | 1,808,163 | +2.7% | 0.32% | +25.1% |
| PAR | Buy | PAR TECHNOLOGY CORP | $8,637,000 | -55.3% | 671,633 | +6.9% | 0.32% | -45.7% |
| ONDK | Sell | ON DECK CAP INC | $8,574,000 | -63.5% | 5,659,644 | -0.2% | 0.32% | -55.6% |
| HTZGQ | Sell | HERTZ GLOBAL HLDGS INCcall | $8,034,000 | -62.0% | 1,300,000 | -3.1% | 0.30% | -53.8% |
| PTON | New | PELOTON INTERACTIVE INC | $7,965,000 | – | 300,000 | +100.0% | 0.30% | – |
| WYND | New | WYNDHAM DESTINATIONS INCcall | $7,697,000 | – | 354,700 | +100.0% | 0.29% | – |
| PLNT | New | PLANET FITNESS INCcl a | $7,419,000 | – | 152,335 | +100.0% | 0.28% | – |
| CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $7,332,000 | +29.7% | 1,432,032 | +15.5% | 0.28% | +58.0% |
| VMD | VIEMED HEALTHCARE INC | $7,131,000 | -24.0% | 1,498,100 | 0.0% | 0.27% | -7.6% | |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $6,322,000 | -13.4% | 1,446,749 | +35.0% | 0.24% | +5.3% |
| RFL | RAFAEL HLDGS INC | $6,099,000 | -29.6% | 485,366 | 0.0% | 0.23% | -14.6% | |
| HAL | New | HALLIBURTON COcall | $6,070,000 | – | 886,200 | +100.0% | 0.23% | – |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $6,037,000 | – | 556,584 | +100.0% | 0.23% | – |
| XELA | Buy | EXELA TECHNOLOGIES INC | $5,694,000 | +9.3% | 27,777,887 | +117.4% | 0.21% | +33.1% |
| SRL | SCULLY ROYALTY LTD | $5,677,000 | -39.3% | 753,885 | 0.0% | 0.21% | -26.0% | |
| INMD | New | INMODE LTD | $5,665,000 | – | 263,499 | +100.0% | 0.21% | – |
| CZR | New | CAESARS ENTMT CORP | $5,408,000 | – | 800,000 | +100.0% | 0.20% | – |
| LINC | LINCOLN EDL SVCS CORP | $5,361,000 | -24.1% | 2,436,805 | 0.0% | 0.20% | -7.8% | |
| HTZGQ | Buy | HERTZ GLOBAL HLDGS INC | $5,247,000 | -55.7% | 849,052 | +12.9% | 0.20% | -46.0% |
| INSUU | INSURANCE ACQUISITION CORPunit 03/31/2024 | $5,190,000 | -2.4% | 500,000 | 0.0% | 0.19% | +18.3% | |
| NATR | NATURES SUNSHINE PRODS INC | $4,856,000 | -9.0% | 597,310 | 0.0% | 0.18% | +11.0% | |
| ENT | GLOBAL EAGLE ENTMT INC | $4,578,000 | -68.5% | 29,031,542 | 0.0% | 0.17% | -61.7% | |
| GLMD | Buy | GALMED PHARMACEUTICALS LTD | $4,511,000 | -11.2% | 1,303,652 | +48.3% | 0.17% | +7.6% |
| SIC | Buy | SELECT INTERIOR CONCEPTS INCcl a | $4,444,000 | -53.7% | 2,147,039 | +101.3% | 0.17% | -43.7% |
| ZVO | ZOVIO INC | $4,378,000 | -19.9% | 2,653,087 | 0.0% | 0.16% | -2.4% | |
| FALCON MINERALS CORP | $4,180,000 | -69.5% | 1,944,144 | 0.0% | 0.16% | -62.9% | ||
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $3,969,000 | +34.1% | 9,566,844 | +9.1% | 0.15% | +63.7% |
| PENN | New | PENN NATL GAMING INCput | $3,795,000 | – | 300,000 | +100.0% | 0.14% | – |
| APEN | Buy | APOLLO ENDOSURGERY INC | $3,549,000 | -32.8% | 1,848,672 | +2.1% | 0.13% | -18.4% |
| NEOS | NEOS THERAPEUTICS INC | $3,458,000 | -50.3% | 4,610,000 | 0.0% | 0.13% | -39.3% | |
| FBIO | Buy | FORTRESS BIOTECH INC | $3,456,000 | +230.1% | 1,828,800 | +349.1% | 0.13% | +303.1% |
| TA | TRAVELCENTERS OF AMERICA INC | $3,298,000 | -43.0% | 337,390 | 0.0% | 0.12% | -30.3% | |
| PRTY | Sell | PARTY CITY HOLDCO INC | $3,269,000 | -81.8% | 7,133,136 | -6.9% | 0.12% | -77.9% |
| SSKN | Buy | STRATA SKIN SCIENCES INC | $3,088,000 | -49.0% | 3,251,001 | +14.0% | 0.12% | -38.0% |
| CATS | New | CATASYS INC | $2,987,000 | – | 196,095 | +100.0% | 0.11% | – |
| STRM | STREAMLINE HEALTH SOLUTIONS | $2,341,000 | -38.8% | 2,753,599 | 0.0% | 0.09% | -25.4% | |
| CZR | Sell | CAESARS ENTMT CORPcall | $2,238,000 | -95.1% | 331,000 | -90.1% | 0.08% | -94.0% |
| AFI | Buy | ARMSTRONG FLOORING INC | $2,226,000 | -65.9% | 1,556,435 | +1.7% | 0.08% | -58.7% |
| TFFP | Buy | TFF PHARMACEUTICALS INC | $2,224,000 | -20.8% | 579,217 | +10.3% | 0.08% | -4.6% |
| DMAC | New | DIAMEDICA THERAPEUTICS INC | $2,141,000 | – | 750,000 | +100.0% | 0.08% | – |
| DVD | DOVER MOTORSPORTS INC | $2,119,000 | -32.8% | 1,695,541 | 0.0% | 0.08% | -18.6% | |
| ACER | ACER THERAPEUTICS INC | $1,971,000 | -50.4% | 990,655 | 0.0% | 0.07% | -39.3% | |
| HTGM | Buy | HTG MOLECULAR DIAGNOSTICS IN | $1,645,000 | -53.1% | 5,060,160 | +1.2% | 0.06% | -42.6% |
| MACK | MERRIMACK PHARMACEUTICALS IN | $1,607,000 | -31.8% | 747,635 | 0.0% | 0.06% | -17.8% | |
| NNI | New | NELNET INCcl a | $1,585,000 | – | 34,900 | +100.0% | 0.06% | – |
| EMMS | EMMIS COMMUNICATIONS CORP | $1,564,000 | -50.4% | 781,783 | 0.0% | 0.06% | -39.2% | |
| DARIOHEALTH CORP | $1,454,000 | +3.6% | 214,091 | 0.0% | 0.05% | +25.6% | ||
| AGS | New | PLAYAGS INC | $1,097,000 | – | 413,804 | +100.0% | 0.04% | – |
| EBIX | New | EBIX INC | $1,017,000 | – | 66,997 | +100.0% | 0.04% | – |
| PHGEU | Sell | BIOMX INCunit 10/16/2024 | $585,000 | -38.6% | 87,299 | -12.7% | 0.02% | -24.1% |
| MDIA | New | MEDIACO HLDG INCcl a | $401,000 | – | 98,894 | +100.0% | 0.02% | – |
| ALTGWS | New | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $314,000 | – | 187,500 | +100.0% | 0.01% | – |
| MOTS | MOTUS GI HLDGS INC | $273,000 | -71.5% | 417,708 | 0.0% | 0.01% | -65.5% | |
| FALCON MINERALS CORP*w exp 07/21/202 | $236,000 | -79.9% | 878,022 | 0.0% | 0.01% | -75.0% | ||
| ELVT | Exit | ELEVATE CREDIT INC | $0 | – | -483,068 | -100.0% | -0.07% | – |
| EVRI | Exit | EVERI HLDGS INC | $0 | – | -250,000 | -100.0% | -0.10% | – |
| ARYAU | Exit | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $0 | – | -452,944 | -100.0% | -0.16% | – |
| IGT | Exit | INTERNATIONAL GAME TECHNOLOGcall | $0 | – | -500,000 | -100.0% | -0.23% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -300,000 | -100.0% | -0.37% | – |
| RH | Exit | RHcall | $0 | – | -269,500 | -100.0% | -1.77% | – |
| FCAU | Exit | FIAT CHRYSLER AUTOMOBILES Ncall | $0 | – | -4,170,000 | -100.0% | -1.89% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -6,544,347 | -100.0% | -4.02% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -2,250,000 | -100.0% | -6.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.